Table 1.

Overexpression of ENO1 in cancers and its clinical correlations

Cancer type	ENO1 overexpression	Clinical correlation	References
Breast	mRNA & protein	disease progression, poor distant metastasis-free survival, overall survival, chemoresistance, radiation resistance	Tsu et al.,33 Zhang et al.,45 Gao et al.,58 Cancemi et al.,63
Colorectal	mRNA & protein	disease progression, overall survival	Zhan et al.,20 Liu et al.,77
Eye	mRNA & protein	disease progression, overall survival	Liu et al.,29
Gastric	mRNA & protein	disease progression, overall survival, chemoresistance	Sun et al.,15, 21, 22, 23, 24, 25 Qiao et al.,46
Glioma	mRNA & protein	disease progression	Song et al.,23
Head and neck	mRNA & protein	overall survival, poor disease-free survival	Tsai et al.,17
Leukemia	protein	disease progression	Griggio et al.,40
Liver	mRNA & protein	disease progression	Yu et al.,30 Takashima et al.,34, 35 Hamaguchi et al.,34, 35
Lung	mRNA & protein	disease progression	Chang et al.,13 He et al.,14 Fu et al.,15 Zhang et al.,16 Almaguel et al.,43 Chen et al.,47
Pancreas	mRNA & protein	disease progression, overall survival, chemoresistance	Yin et al.,19 Principe et al.,26,32 Wang et al.,27 Tomaino et al.,37 Wang et al.,84 Peng et al.,86 Cappello et al.,87,88 Di Caro et al.,89
Prostrate	mRNA & protein	disease progression, chemoresistance	Satani et al.,83
Skin	protein	disease progression	Zhang et al.,45 De Rosa et al.,73